nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—HTR2A—chronic obstructive pulmonary disease	0.298	1	CbGaD
Promethazine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.116	0.242	CbGbCtD
Promethazine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0739	0.154	CbGbCtD
Promethazine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0643	0.134	CbGbCtD
Promethazine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0593	0.124	CbGbCtD
Promethazine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0265	0.0554	CbGbCtD
Promethazine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0265	0.0554	CbGbCtD
Promethazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0242	0.0507	CbGbCtD
Promethazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0242	0.0507	CbGbCtD
Promethazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0216	0.0452	CbGbCtD
Promethazine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0201	0.042	CbGbCtD
Promethazine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0114	0.0239	CbGbCtD
Promethazine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0108	0.0226	CbGbCtD
Promethazine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00827	0.259	CbGeAlD
Promethazine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.003	0.094	CbGeAlD
Promethazine—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.013	CcSEcCtD
Promethazine—Paralysis—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.0124	CcSEcCtD
Promethazine—Paralysis—Formoterol—chronic obstructive pulmonary disease	0.00136	0.0124	CcSEcCtD
Promethazine—Dermatitis contact—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.0112	CcSEcCtD
Promethazine—Abscess—Formoterol—chronic obstructive pulmonary disease	0.00119	0.0109	CcSEcCtD
Promethazine—Abscess—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.0109	CcSEcCtD
Promethazine—Coma—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.0103	CcSEcCtD
Promethazine—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00954	CcSEcCtD
Promethazine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00947	CcSEcCtD
Promethazine—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00919	CcSEcCtD
Promethazine—Dermatitis contact—Arformoterol—chronic obstructive pulmonary disease	0.000931	0.00851	CcSEcCtD
Promethazine—Dermatitis contact—Formoterol—chronic obstructive pulmonary disease	0.000931	0.00851	CcSEcCtD
Promethazine—CALM3—bronchus—chronic obstructive pulmonary disease	0.000873	0.0273	CbGeAlD
Promethazine—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.000859	0.00786	CcSEcCtD
Promethazine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.000858	0.00784	CcSEcCtD
Promethazine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000854	0.00781	CcSEcCtD
Promethazine—CALM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000854	0.0267	CbGeAlD
Promethazine—CALM2—respiratory system—chronic obstructive pulmonary disease	0.000833	0.0261	CbGeAlD
Promethazine—CALM1—respiratory system—chronic obstructive pulmonary disease	0.000829	0.0259	CbGeAlD
Promethazine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.000806	0.00737	CcSEcCtD
Promethazine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000796	0.00728	CcSEcCtD
Promethazine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000788	0.00721	CcSEcCtD
Promethazine—CALM3—trachea—chronic obstructive pulmonary disease	0.000784	0.0245	CbGeAlD
Promethazine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00078	0.00713	CcSEcCtD
Promethazine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000766	0.024	CbGeAlD
Promethazine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.000764	0.00699	CcSEcCtD
Promethazine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00076	0.00695	CcSEcCtD
Promethazine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000751	0.00686	CcSEcCtD
Promethazine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000751	0.00686	CcSEcCtD
Promethazine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.000749	0.00685	CcSEcCtD
Promethazine—CALM2—connective tissue—chronic obstructive pulmonary disease	0.000733	0.0229	CbGeAlD
Promethazine—CALM1—connective tissue—chronic obstructive pulmonary disease	0.00073	0.0228	CbGeAlD
Promethazine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000717	0.00656	CcSEcCtD
Promethazine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000709	0.00648	CcSEcCtD
Promethazine—CHRM1—trachea—chronic obstructive pulmonary disease	0.000703	0.022	CbGeAlD
Promethazine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000688	0.0063	CcSEcCtD
Promethazine—CALM2—bronchus—chronic obstructive pulmonary disease	0.000686	0.0215	CbGeAlD
Promethazine—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000685	0.0214	CbGeAlD
Promethazine—CALM1—bronchus—chronic obstructive pulmonary disease	0.000683	0.0214	CbGeAlD
Promethazine—CALM2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000671	0.021	CbGeAlD
Promethazine—CALM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000668	0.0209	CbGeAlD
Promethazine—Abscess—Prednisolone—chronic obstructive pulmonary disease	0.000645	0.0059	CcSEcCtD
Promethazine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000639	0.00585	CcSEcCtD
Promethazine—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000619	0.0194	CbGeAlD
Promethazine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.00564	CcSEcCtD
Promethazine—CALM2—trachea—chronic obstructive pulmonary disease	0.000616	0.0193	CbGeAlD
Promethazine—CALM1—trachea—chronic obstructive pulmonary disease	0.000613	0.0192	CbGeAlD
Promethazine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000605	0.0189	CbGeAlD
Promethazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000599	0.00548	CcSEcCtD
Promethazine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.00541	CcSEcCtD
Promethazine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000591	0.00541	CcSEcCtD
Promethazine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00533	CcSEcCtD
Promethazine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000579	0.00529	CcSEcCtD
Promethazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000576	0.00526	CcSEcCtD
Promethazine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000571	0.00522	CcSEcCtD
Promethazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000566	0.00518	CcSEcCtD
Promethazine—CALM3—lung—chronic obstructive pulmonary disease	0.000563	0.0176	CbGeAlD
Promethazine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.0051	CcSEcCtD
Promethazine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00508	CcSEcCtD
Promethazine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000546	0.00499	CcSEcCtD
Promethazine—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.00054	0.102	CrCbGaD
Promethazine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000532	0.0167	CbGeAlD
Promethazine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000531	0.00486	CcSEcCtD
Promethazine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000526	0.00481	CcSEcCtD
Promethazine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.00479	CcSEcCtD
Promethazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000516	0.00472	CcSEcCtD
Promethazine—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.00051	0.016	CbGeAlD
Promethazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.00464	CcSEcCtD
Promethazine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000505	0.0158	CbGeAlD
Promethazine—CHRM1—lung—chronic obstructive pulmonary disease	0.000505	0.0158	CbGeAlD
Promethazine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000503	0.0046	CcSEcCtD
Promethazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00455	CcSEcCtD
Promethazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000497	0.00455	CcSEcCtD
Promethazine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000487	0.0152	CbGeAlD
Promethazine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00444	CcSEcCtD
Promethazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000481	0.0044	CcSEcCtD
Promethazine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00437	CcSEcCtD
Promethazine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000475	0.00435	CcSEcCtD
Promethazine—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.000472	0.00432	CcSEcCtD
Promethazine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000469	0.00429	CcSEcCtD
Promethazine—Abscess—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00429	CcSEcCtD
Promethazine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00422	CcSEcCtD
Promethazine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.0042	CcSEcCtD
Promethazine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000458	0.00418	CcSEcCtD
Promethazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000453	0.00414	CcSEcCtD
Promethazine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00412	CcSEcCtD
Promethazine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.0041	CcSEcCtD
Promethazine—HRH1—trachea—chronic obstructive pulmonary disease	0.000447	0.014	CbGeAlD
Promethazine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000445	0.0139	CbGeAlD
Promethazine—CALM2—lung—chronic obstructive pulmonary disease	0.000442	0.0138	CbGeAlD
Promethazine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00404	CcSEcCtD
Promethazine—CALM1—lung—chronic obstructive pulmonary disease	0.00044	0.0138	CbGeAlD
Promethazine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000438	0.00401	CcSEcCtD
Promethazine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000438	0.004	CcSEcCtD
Promethazine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00397	CcSEcCtD
Promethazine—Delirium—Prednisone—chronic obstructive pulmonary disease	0.000431	0.00394	CcSEcCtD
Promethazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00394	CcSEcCtD
Promethazine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00391	CcSEcCtD
Promethazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00389	CcSEcCtD
Promethazine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00386	CcSEcCtD
Promethazine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00386	CcSEcCtD
Promethazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000418	0.00382	CcSEcCtD
Promethazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000417	0.00381	CcSEcCtD
Promethazine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00381	CcSEcCtD
Promethazine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00381	CcSEcCtD
Promethazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000415	0.00379	CcSEcCtD
Promethazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000413	0.00377	CcSEcCtD
Promethazine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00041	0.00375	CcSEcCtD
Promethazine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000407	0.0127	CbGeAlD
Promethazine—DRD2—lung—chronic obstructive pulmonary disease	0.000407	0.0127	CbGeAlD
Promethazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00372	CcSEcCtD
Promethazine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000404	0.0037	CcSEcCtD
Promethazine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000404	0.0037	CcSEcCtD
Promethazine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00366	CcSEcCtD
Promethazine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00366	CcSEcCtD
Promethazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00365	CcSEcCtD
Promethazine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00365	CcSEcCtD
Promethazine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00362	CcSEcCtD
Promethazine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00362	CcSEcCtD
Promethazine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00356	CcSEcCtD
Promethazine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00355	CcSEcCtD
Promethazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00353	CcSEcCtD
Promethazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00353	CcSEcCtD
Promethazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000384	0.00351	CcSEcCtD
Promethazine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.00349	CcSEcCtD
Promethazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00346	CcSEcCtD
Promethazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00346	CcSEcCtD
Promethazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00346	CcSEcCtD
Promethazine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00345	CcSEcCtD
Promethazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00344	CcSEcCtD
Promethazine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00342	CcSEcCtD
Promethazine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000373	0.0117	CbGeAlD
Promethazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000371	0.00339	CcSEcCtD
Promethazine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00335	CcSEcCtD
Promethazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00333	CcSEcCtD
Promethazine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00333	CcSEcCtD
Promethazine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00333	CcSEcCtD
Promethazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00327	CcSEcCtD
Promethazine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00326	CcSEcCtD
Promethazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000356	0.00326	CcSEcCtD
Promethazine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000349	0.0032	CcSEcCtD
Promethazine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.0032	CcSEcCtD
Promethazine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000349	0.0032	CcSEcCtD
Promethazine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00319	CcSEcCtD
Promethazine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00314	CcSEcCtD
Promethazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00314	CcSEcCtD
Promethazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00314	CcSEcCtD
Promethazine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00313	CcSEcCtD
Promethazine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00313	CcSEcCtD
Promethazine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00307	CcSEcCtD
Promethazine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00307	CcSEcCtD
Promethazine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00307	CcSEcCtD
Promethazine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00307	CcSEcCtD
Promethazine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000331	0.0104	CbGeAlD
Promethazine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00302	CcSEcCtD
Promethazine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00301	CcSEcCtD
Promethazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00301	CcSEcCtD
Promethazine—CYP2B6—lung—chronic obstructive pulmonary disease	0.000329	0.0103	CbGeAlD
Promethazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000328	0.003	CcSEcCtD
Promethazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.003	CcSEcCtD
Promethazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00296	CcSEcCtD
Promethazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00295	CcSEcCtD
Promethazine—HRH1—lung—chronic obstructive pulmonary disease	0.000321	0.0101	CbGeAlD
Promethazine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00291	CcSEcCtD
Promethazine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.0029	CcSEcCtD
Promethazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.0029	CcSEcCtD
Promethazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00287	CcSEcCtD
Promethazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00287	CcSEcCtD
Promethazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000312	0.00286	CcSEcCtD
Promethazine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00286	CcSEcCtD
Promethazine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00284	CcSEcCtD
Promethazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00283	CcSEcCtD
Promethazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00278	CcSEcCtD
Promethazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00278	CcSEcCtD
Promethazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000302	0.00276	CcSEcCtD
Promethazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00273	CcSEcCtD
Promethazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00273	CcSEcCtD
Promethazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00272	CcSEcCtD
Promethazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00271	CcSEcCtD
Promethazine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00271	CcSEcCtD
Promethazine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00271	CcSEcCtD
Promethazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00269	CcSEcCtD
Promethazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00268	CcSEcCtD
Promethazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000292	0.00267	CcSEcCtD
Promethazine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00265	CcSEcCtD
Promethazine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00265	CcSEcCtD
Promethazine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00265	CcSEcCtD
Promethazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00263	CcSEcCtD
Promethazine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00263	CcSEcCtD
Promethazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00263	CcSEcCtD
Promethazine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00263	CcSEcCtD
Promethazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00262	CcSEcCtD
Promethazine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000284	0.0026	CcSEcCtD
Promethazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00258	CcSEcCtD
Promethazine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00257	CcSEcCtD
Promethazine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00255	CcSEcCtD
Promethazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000278	0.00255	CcSEcCtD
Promethazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000278	0.00254	CcSEcCtD
Promethazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00253	CcSEcCtD
Promethazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00253	CcSEcCtD
Promethazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00253	CcSEcCtD
Promethazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00252	CcSEcCtD
Promethazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.00252	CcSEcCtD
Promethazine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.0025	CcSEcCtD
Promethazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00248	CcSEcCtD
Promethazine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00248	CcSEcCtD
Promethazine—HTR2A—lung—chronic obstructive pulmonary disease	0.000268	0.00839	CbGeAlD
Promethazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.0024	CcSEcCtD
Promethazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.0024	CcSEcCtD
Promethazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00239	CcSEcCtD
Promethazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00239	CcSEcCtD
Promethazine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00239	CcSEcCtD
Promethazine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00235	CcSEcCtD
Promethazine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000245	0.00766	CbGeAlD
Promethazine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00221	CcSEcCtD
Promethazine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00221	CcSEcCtD
Promethazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00217	CcSEcCtD
Promethazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00217	CcSEcCtD
Promethazine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00216	CcSEcCtD
Promethazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00213	CcSEcCtD
Promethazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.0021	CcSEcCtD
Promethazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00023	0.0021	CcSEcCtD
Promethazine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00209	CcSEcCtD
Promethazine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00208	CcSEcCtD
Promethazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00206	CcSEcCtD
Promethazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00205	CcSEcCtD
Promethazine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.00204	CcSEcCtD
Promethazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00203	CcSEcCtD
Promethazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00203	CcSEcCtD
Promethazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00199	CcSEcCtD
Promethazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00199	CcSEcCtD
Promethazine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000212	0.0399	CrCbGaD
Promethazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00194	CcSEcCtD
Promethazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00194	CcSEcCtD
Promethazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00194	CcSEcCtD
Promethazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00194	CcSEcCtD
Promethazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00193	CcSEcCtD
Promethazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00193	CcSEcCtD
Promethazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00192	CcSEcCtD
Promethazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00192	CcSEcCtD
Promethazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000208	0.0019	CcSEcCtD
Promethazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000207	0.0019	CcSEcCtD
Promethazine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00189	CcSEcCtD
Promethazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00189	CcSEcCtD
Promethazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00183	CcSEcCtD
Promethazine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00183	CcSEcCtD
Promethazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00183	CcSEcCtD
Promethazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00182	CcSEcCtD
Promethazine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.0371	CrCbGaD
Promethazine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00179	CcSEcCtD
Promethazine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00177	CcSEcCtD
Promethazine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00173	CcSEcCtD
Promethazine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00169	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00166	CcSEcCtD
Promethazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00166	CcSEcCtD
Promethazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.000179	0.0337	CrCbGaD
Promethazine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00164	CcSEcCtD
Promethazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00162	CcSEcCtD
Promethazine—ABCB1—lung—chronic obstructive pulmonary disease	0.000176	0.0055	CbGeAlD
Promethazine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000167	0.0313	CrCbGaD
Promethazine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00152	CcSEcCtD
Promethazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00151	CcSEcCtD
Promethazine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00148	CcSEcCtD
Promethazine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00142	CcSEcCtD
Promethazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000153	0.0014	CcSEcCtD
Promethazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00137	CcSEcCtD
Promethazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00136	CcSEcCtD
Promethazine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00133	CcSEcCtD
Promethazine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000142	0.0013	CcSEcCtD
Promethazine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00128	CcSEcCtD
Promethazine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00126	CcSEcCtD
Promethazine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00121	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00121	CcSEcCtD
Promethazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.0246	CrCbGaD
Promethazine—Shock—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00119	CcSEcCtD
Promethazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00118	CcSEcCtD
Promethazine—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.0231	CrCbGaD
Promethazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.0011	CcSEcCtD
Promethazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00109	CcSEcCtD
Promethazine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00106	CcSEcCtD
Promethazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000115	0.0216	CrCbGaD
Promethazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00105	CcSEcCtD
Promethazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00105	CcSEcCtD
Promethazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00105	CcSEcCtD
Promethazine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00104	CcSEcCtD
Promethazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00104	CcSEcCtD
Promethazine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000114	0.0214	CrCbGaD
Promethazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00103	CcSEcCtD
Promethazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000112	0.0211	CrCbGaD
Promethazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000111	0.0208	CrCbGaD
Promethazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.000109	0.0205	CrCbGaD
Promethazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000997	CcSEcCtD
Promethazine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.000105	0.0197	CrCbGaD
Promethazine—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000104	0.0196	CrCbGaD
Promethazine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.0195	CrCbGaD
Promethazine—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000101	0.0189	CrCbGaD
Promethazine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	9.98e-05	0.0188	CrCbGaD
Promethazine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	9.76e-05	0.0183	CrCbGaD
Promethazine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000868	CcSEcCtD
Promethazine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	9.36e-05	0.0176	CrCbGaD
Promethazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.000856	CcSEcCtD
Promethazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	9.32e-05	0.0175	CrCbGaD
Promethazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	9.2e-05	0.0173	CrCbGaD
Promethazine—Desipramine—SLC6A4—chronic obstructive pulmonary disease	9.16e-05	0.0172	CrCbGaD
Promethazine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	9.09e-05	0.0171	CrCbGaD
Promethazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	9.06e-05	0.017	CrCbGaD
Promethazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000828	CcSEcCtD
Promethazine—Methadone—CYP1A2—chronic obstructive pulmonary disease	9.04e-05	0.017	CrCbGaD
Promethazine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	8.96e-05	0.0168	CrCbGaD
Promethazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.0008	CcSEcCtD
Promethazine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	8.75e-05	0.0164	CrCbGaD
Promethazine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	8.71e-05	0.0164	CrCbGaD
Promethazine—Rash—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000763	CcSEcCtD
Promethazine—Desipramine—CYP1A2—chronic obstructive pulmonary disease	8.34e-05	0.0157	CrCbGaD
Promethazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000762	CcSEcCtD
Promethazine—Headache—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000758	CcSEcCtD
Promethazine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	8.24e-05	0.0155	CrCbGaD
Promethazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	8.08e-05	0.0152	CrCbGaD
Promethazine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	8.05e-05	0.0151	CrCbGaD
Promethazine—Acepromazine—ALB—chronic obstructive pulmonary disease	7.87e-05	0.0148	CrCbGaD
Promethazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	7.87e-05	0.0148	CrCbGaD
Promethazine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	7.77e-05	0.0146	CrCbGaD
Promethazine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	7.72e-05	0.0145	CrCbGaD
Promethazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	7.7e-05	0.0145	CrCbGaD
Promethazine—Doxepin—HTR2A—chronic obstructive pulmonary disease	7.67e-05	0.0144	CrCbGaD
Promethazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	7.65e-05	0.0144	CrCbGaD
Promethazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	7.57e-05	0.0142	CrCbGaD
Promethazine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	7.56e-05	0.0142	CrCbGaD
Promethazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	7.11e-05	0.0134	CrCbGaD
Promethazine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	7.07e-05	0.0133	CrCbGaD
Promethazine—Desipramine—HTR2A—chronic obstructive pulmonary disease	7.04e-05	0.0132	CrCbGaD
Promethazine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	7.03e-05	0.0132	CrCbGaD
Promethazine—Promazine—HTR2A—chronic obstructive pulmonary disease	6.82e-05	0.0128	CrCbGaD
Promethazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	6e-05	0.0113	CrCbGaD
Promethazine—Clomipramine—ALB—chronic obstructive pulmonary disease	5.98e-05	0.0112	CrCbGaD
Promethazine—Imipramine—HTR2A—chronic obstructive pulmonary disease	5.97e-05	0.0112	CrCbGaD
Promethazine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	5.93e-05	0.0111	CrCbGaD
Promethazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	4.11e-05	0.00771	CrCbGaD
Promethazine—Amitriptyline—ALB—chronic obstructive pulmonary disease	4.06e-05	0.00763	CrCbGaD
Promethazine—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.63e-06	0.000111	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.6e-06	0.000111	CbGpPWpGaD
Promethazine—CALM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.5e-06	0.00011	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.5e-06	0.00011	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.49e-06	0.00011	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.44e-06	0.000109	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.36e-06	0.000108	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.35e-06	0.000108	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.34e-06	0.000108	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.31e-06	0.000107	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.3e-06	0.000107	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.29e-06	0.000107	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.29e-06	0.000107	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.28e-06	0.000107	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.26e-06	0.000107	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.24e-06	0.000106	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.23e-06	0.000106	CbGpPWpGaD
Promethazine—CALM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	0.000106	CbGpPWpGaD
Promethazine—CALM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	0.000106	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.21e-06	0.000106	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.21e-06	0.000106	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.21e-06	0.000106	CbGpPWpGaD
Promethazine—CALM3—Disease—NOS2—chronic obstructive pulmonary disease	8.21e-06	0.000106	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.21e-06	0.000106	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.19e-06	0.000106	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.15e-06	0.000105	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.13e-06	0.000105	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.12e-06	0.000105	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.98e-06	0.000103	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.97e-06	0.000103	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	7.96e-06	0.000103	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.95e-06	0.000103	CbGpPWpGaD
Promethazine—CALM2—Disease—NOS2—chronic obstructive pulmonary disease	7.94e-06	0.000102	CbGpPWpGaD
Promethazine—CALM1—Disease—NOS2—chronic obstructive pulmonary disease	7.94e-06	0.000102	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.92e-06	0.000102	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.86e-06	0.000101	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.85e-06	0.000101	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.83e-06	0.000101	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	7.7e-06	9.93e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	7.7e-06	9.93e-05	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	7.64e-06	9.86e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.58e-06	9.79e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.55e-06	9.74e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.43e-06	9.59e-05	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—TP53—chronic obstructive pulmonary disease	7.42e-06	9.57e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.41e-06	9.57e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.39e-06	9.54e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.39e-06	9.54e-05	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	7.39e-06	9.54e-05	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	7.39e-06	9.54e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.37e-06	9.51e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.34e-06	9.47e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.34e-06	9.47e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.3e-06	9.41e-05	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.29e-06	9.41e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.29e-06	9.41e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.28e-06	9.4e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.28e-06	9.39e-05	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—TP53—chronic obstructive pulmonary disease	7.18e-06	9.26e-05	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—TP53—chronic obstructive pulmonary disease	7.18e-06	9.26e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.98e-06	9e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.97e-06	8.99e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.94e-06	8.95e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.93e-06	8.94e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—SERPINE1—chronic obstructive pulmonary disease	6.91e-06	8.92e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.91e-06	8.91e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	6.9e-06	8.9e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.89e-06	8.9e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.87e-06	8.87e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.81e-06	8.79e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.79e-06	8.77e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.71e-06	8.66e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.71e-06	8.66e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—SERPINE1—chronic obstructive pulmonary disease	6.69e-06	8.63e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—SERPINE1—chronic obstructive pulmonary disease	6.69e-06	8.63e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.67e-06	8.6e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.67e-06	8.6e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.64e-06	8.56e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.63e-06	8.56e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	6.6e-06	8.52e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—NOS3—chronic obstructive pulmonary disease	6.6e-06	8.51e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.59e-06	8.5e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.44e-06	8.31e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.42e-06	8.28e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.42e-06	8.28e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.4e-06	8.26e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—NOS3—chronic obstructive pulmonary disease	6.38e-06	8.24e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—NOS3—chronic obstructive pulmonary disease	6.38e-06	8.24e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.35e-06	8.19e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.31e-06	8.14e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.21e-06	8.01e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.17e-06	7.96e-05	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.11e-06	7.89e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.11e-06	7.88e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.1e-06	7.87e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1B—chronic obstructive pulmonary disease	6.08e-06	7.85e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.08e-06	7.84e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.07e-06	7.83e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.06e-06	7.82e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.02e-06	7.76e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6e-06	7.74e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.98e-06	7.72e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.97e-06	7.7e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.97e-06	7.7e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	5.94e-06	7.66e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.93e-06	7.65e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.92e-06	7.63e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.92e-06	7.63e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.92e-06	7.63e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1B—chronic obstructive pulmonary disease	5.88e-06	7.59e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1B—chronic obstructive pulmonary disease	5.88e-06	7.59e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.83e-06	7.52e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.82e-06	7.51e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.8e-06	7.48e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.78e-06	7.46e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ALB—chronic obstructive pulmonary disease	5.78e-06	7.45e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.73e-06	7.39e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.71e-06	7.37e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.68e-06	7.33e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.67e-06	7.31e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.66e-06	7.3e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	7.21e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	7.21e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.57e-06	7.18e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.55e-06	7.17e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.54e-06	7.14e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.53e-06	7.13e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.52e-06	7.12e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.47e-06	7.05e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.45e-06	7.03e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.43e-06	7.01e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.35e-06	6.9e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.35e-06	6.9e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.32e-06	6.87e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.2e-06	6.71e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.1e-06	6.58e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.07e-06	6.54e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.02e-06	6.48e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.94e-06	6.37e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.93e-06	6.36e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.91e-06	6.34e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.91e-06	6.33e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.91e-06	6.33e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.9e-06	6.32e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.85e-06	6.26e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.84e-06	6.25e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.84e-06	6.24e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.77e-06	6.16e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.7e-06	6.06e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.69e-06	6.05e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.68e-06	6.04e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.68e-06	6.04e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.67e-06	6.03e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.66e-06	6.01e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EGFR—chronic obstructive pulmonary disease	4.63e-06	5.98e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.62e-06	5.96e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.61e-06	5.95e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.6e-06	5.93e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.54e-06	5.86e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EGFR—chronic obstructive pulmonary disease	4.48e-06	5.78e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EGFR—chronic obstructive pulmonary disease	4.48e-06	5.78e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.47e-06	5.77e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.47e-06	5.77e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.47e-06	5.77e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.47e-06	5.76e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.46e-06	5.75e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.44e-06	5.73e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.43e-06	5.71e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.39e-06	5.66e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.38e-06	5.65e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.37e-06	5.64e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—TGFB1—chronic obstructive pulmonary disease	4.36e-06	5.63e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.28e-06	5.52e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—chronic obstructive pulmonary disease	4.28e-06	5.52e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—chronic obstructive pulmonary disease	4.22e-06	5.45e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—chronic obstructive pulmonary disease	4.22e-06	5.45e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.19e-06	5.4e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—chronic obstructive pulmonary disease	4.14e-06	5.34e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—chronic obstructive pulmonary disease	4.14e-06	5.34e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.13e-06	5.32e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.1e-06	5.29e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.09e-06	5.28e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.09e-06	5.28e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.08e-06	5.26e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.01e-06	5.18e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4e-06	5.16e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.99e-06	5.15e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.98e-06	5.13e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.97e-06	5.12e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.97e-06	5.12e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.95e-06	5.09e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.94e-06	5.08e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.93e-06	5.07e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.92e-06	5.06e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.91e-06	5.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.9e-06	5.03e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.77e-06	4.87e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.77e-06	4.87e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.74e-06	4.83e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.71e-06	4.78e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.68e-06	4.75e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.67e-06	4.74e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.67e-06	4.73e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.66e-06	4.72e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.65e-06	4.71e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.61e-06	4.66e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.61e-06	4.66e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.6e-06	4.65e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.6e-06	4.65e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.59e-06	4.63e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-06	4.63e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.59e-06	4.63e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.58e-06	4.62e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—chronic obstructive pulmonary disease	3.56e-06	4.6e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.54e-06	4.57e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.53e-06	4.56e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—chronic obstructive pulmonary disease	3.45e-06	4.45e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—chronic obstructive pulmonary disease	3.45e-06	4.45e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.33e-06	4.3e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—chronic obstructive pulmonary disease	3.29e-06	4.24e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.22e-06	4.16e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.22e-06	4.16e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—chronic obstructive pulmonary disease	3.18e-06	4.1e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—chronic obstructive pulmonary disease	3.18e-06	4.1e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.08e-06	3.97e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.06e-06	3.94e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.03e-06	3.91e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.02e-06	3.9e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.01e-06	3.89e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3e-06	3.88e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3e-06	3.87e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.98e-06	3.84e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.97e-06	3.83e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.96e-06	3.81e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.96e-06	3.81e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-06	3.74e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.9e-06	3.74e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.82e-06	3.64e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.77e-06	3.58e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.77e-06	3.57e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.76e-06	3.56e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.75e-06	3.55e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.72e-06	3.51e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.72e-06	3.5e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.52e-06	3.25e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-06	3.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.43e-06	3.14e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.3e-06	2.97e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-06	2.87e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.23e-06	2.87e-05	CbGpPWpGaD
